- Immune checkpoint inhibitors and type 1 diabetes mellitus(2019)
Auteurs: Jeroen de Filette, Joeri Pen, Lore Decoster, Bert Bravenboer, Bart Van Der Auwera, Frans K Gorus, Sandrine Aspeslagh, Bart Neyns, Brigitte Velkeniers-Hoebanckx, Aan-Vinay Kharagjitsing
Pagina's: 363-374
Aantal pagina's: 12
- SLC30A8 polymorphism and BMI complement HLA-A*24 as risk factors for poor graft function in islet allograft recipients(2018)
Auteurs: Else Balke, Simke Demeester, DaHae Lee, Pieter Gillard, Robert Hilbrands, Ursule Van De Velde, Bart Van Der Auwera, Zhidong Ling, Bart O Roep, Daniel G Pipeleers, et al.
Pagina's: 1623-1632
Aantal pagina's: 10
- Accelerated progression to Type 1 diabetes in the presence of HLA-A*24 and -B*18 is restricted to multiple-islet autoantibody-positive individuals with distinct HLA-DQ- and autoantibody risk profiles(2018)
Auteurs: Else Balke, Eric Balti Vounsia, Bart Van Der Auwera, Ilse Weets, Olivier Costa, Simke Demeester, Pascale Abrams, Kristina Casteels, Marina Coeckelberghs, Sylvie Tenoutasse, et al.
Pagina's: 1076-1083
Aantal pagina's: 8
- HLA-A*24 carrier status and autoantibody surges posttransplantation associate vith poor functional outcome in recipients of an islet allograft(2016)
Auteurs: Simke Demeester, Else Balke, Bart Van Der Auwera, Pieter Gillard, Robert Hilbrands, DaHae Lee, Ursule Van De Velde, Zhidong Ling, Bart O Roep, Daniel G Pipeleers, et al.
Pagina's: 1060-1064
Aantal pagina's: 5
- Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers(2015)
Auteurs: Bart Van Der Auwera
Pagina's: 381-386
Aantal pagina's: 6
- Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: Relation to autoantibody status and comparison with Belgian patients(2014)
Auteurs: Alahkala Asanghanwa, Frans K Gorus, Ilse Weets, Bart Van Der Auwera, Folefac Aminkeng, Eric Mbunwe, Patrick Goubert, Katrijn Verhaeghen, Daniel G Pipeleers, Bart Keymeulen, et al.
Pagina's: 97-105
Aantal pagina's: 9
- In antibody-positive first-degree relatives of patients with type 1 diabetes, HLA-A*24 and HLA-B*18, but not HLA-B*39, are predictors of impending diabetes with distinct HLA-DQ interactions(2013)
Auteurs: Eric Mbunwe, Bart Van Der Auwera, Ilse Weets, Katelijn Decochez, Evy Vandemeulebroucke, Pieter Gillard, Bart Keymeulen, Christiaan Van Schravendijk, Daniel G Pipeleers, Frans K Gorus
Pagina's: 1964-1970
Aantal pagina's: 7
- HLA-A*24 is an independent predictor of 5-year progression to diabetes in autoantibody positive first-degree relatives of type 1 diabetic patients.(2013)
Auteurs: Eric Mbunwe, Bart Van Der Auwera, Ilse Vermeulen, Simke Demeester, Annelien Van Dalem, Eric Balti Vounsia, S. Van Aken, I Derdelinckx, H. Dorchy, Jean De Schepper, et al.
Pagina's: 1345-1350
Aantal pagina's: 5
- Validation of an enzyme-linked immunosorbent assay for C-peptide analysis in Cameroon(2012)
Auteurs: Alahkala Asanghanwa, Farah Van Genderen, Katrijn Verhaeghen, Bart Van Der Auwera, Christiaan Van Schravendijk
Pagina's: 459-464
Aantal pagina's: 6
- Rare and functional SIAE variants are not associated with autoimmune disease risk in up to 66,924 individuals of European ancestry(2011)
Auteurs: Bart Van Der Auwera
Pagina's: 3-5
Aantal pagina's: 3
